Screening for Tuberculosis in Pregnancy

NACompletedINTERVENTIONAL
Enrollment

310

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

May 31, 2023

Study Completion Date

May 31, 2023

Conditions
Latent Tuberculosis
Interventions
DIAGNOSTIC_TEST

IGRA blood test used as a tool for opt-out screening for latent Tuberculsis infection

All eligible pregnant migrants will be offered an opt-out screening IGRA blood test for latent Tuberculosis infection

Trial Locations (3)

E1 1FR

Royal London Hospital, London

E11 1NR

Whipps Cross Hospital, London

E13 8SL

Newham University Hospital, London

All Listed Sponsors
collaborator

University College, London

OTHER

collaborator

City, University of London

OTHER

collaborator

Imperial College London

OTHER

lead

Queen Mary University of London

OTHER

NCT04098341 - Screening for Tuberculosis in Pregnancy | Biotech Hunter | Biotech Hunter